Cite
Shimomura H, Andachi S, Aono T, et al. Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes. J Pharm Health Care Sci. 2015;1:32doi: 10.1186/s40780-015-0029-0.
Shimomura, H., Andachi, S., Aono, T., Kigure, A., Yamamoto, Y., Miyajima, A., Hirota, T., Imanaka, K., Majima, T., Masuyama, H., Tatsumi, K., & Aoyama, T. (2015). Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes. Journal of pharmaceutical health care and sciences, 132. https://doi.org/10.1186/s40780-015-0029-0
Shimomura, Hitoshi, et al. "Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes." Journal of pharmaceutical health care and sciences vol. 1 (2015): 32. doi: https://doi.org/10.1186/s40780-015-0029-0
Shimomura H, Andachi S, Aono T, Kigure A, Yamamoto Y, Miyajima A, Hirota T, Imanaka K, Majima T, Masuyama H, Tatsumi K, Aoyama T. Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes. J Pharm Health Care Sci. 2015 Nov 14;1:32. doi: 10.1186/s40780-015-0029-0. eCollection 2015. PMID: 26819743; PMCID: PMC4728759.
Copy
Download .nbib